+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Epilepsy Study Consortium Mini-Grant

American Epilepsy Society

The Epilepsy Study Consortium is sponsoring a mini-grant of up to $22,000 for epilepsy fellows to undertake a mentored research project on anti-epileptic drug therapy during their fellowship training and to attend the AES Annual Meeting. The award does not require past experience with research or a specific percentage protected time for research but instead focuses on the mentorship and training experience for the fellow. Applicants may request funding periods of six months to one year.

The project budget can be up to a total of $22,000, with up to $20,000 for direct research costs and up to $2,000 for travel to the AES Annual Meeting. In addition, the ESC will work directly with the awardee to provide funding for the awardee to attend either the Antiepileptic Drug and Device Trials Symposium (AEDD) or the Epilepsy Foundation Pipeline meeting depending on the award year.

Research must focus on anti-epileptic drug therapy, either with clinical, translational, or basic science methods. Funds may be used to support a limited research project or for the collection of preliminary data leading to a larger research effort. Examples of appropriate projects include, but are not limited to, prospective or retrospective studies on treatment outcomes or adverse events in specific populations, or studies enabling randomized controlled trials (such as evaluations of new therapeutic trial methodology).

APPLICATION DEADLINES AND AWARD DATES

 September 2025: Application submission opens through ProposalCentral

 January 22, 2026: Full proposals due

 By May 31, 2026: Awardees notified

 July 1, 2026: Earliest award start date. May be delayed up to 6 months (January 1, 2027).

AI Based Application Success Predictor

⭐ 1. Clear Focus on Epilepsy

AES only funds work that directly advances epilepsy research, including:

Mechanisms of seizure generation/spread

Epileptogenesis

Models of childhood epilepsies

Precision therapeutics

SUDEP and comorbidities

Diagnostics, imaging, computational neuroscience

Translational pathways toward clinical application

Predictor: Your project must be explicitly and centrally about epilepsy, not broadly neuroscience.

⭐ 2. Strong Fit to the Specific AES Award Mechanism

AES awards are sharply matched to career stage and purpose:

• Predoctoral Research Fellowships

Must show strong mentorship, a focused epilepsy project, and training plan.

• Postdoctoral Fellowships

Require a robust mentor, evidence of productivity (first-author papers), and feasibility of independence.

• Early Career Research Grants

Applicants must be faculty within ~5 years of first appointment.

Reviewers look for clear independence, preliminary data, and a trajectory toward R01/NIH-style funding.

• Seed Grants

Designed to generate preliminary data for larger NIH/CDC/NSF grants.

High-risk/high-yield pilot aims are valued.

• Research & Training Fellowships / Infrastructure awards

Focus on developing expertise and building epilepsy research capacity.

Predictor: Choose the mechanism that exactly matches your career stage, independence level, and project maturity.

⭐ 3. Strong Preliminary Data (Even for Fellowships)

AES reviewers consistently reward:

Pilot data that supports feasibility

Clear rationale for hypotheses

Evidence that methods are working

A logical next step built on your lab’s strengths

Predictor: Preliminary data—even modest—is often a make-or-break factor.

⭐ 4. Exceptional Mentorship & Research Environment

Especially for pre/postdoctoral and early career awards, reviewers expect:

A senior, active epilepsy investigator as mentor

Dual mentorship (clinical + basic, computational + electrophysiology) when appropriate

Institutional commitment (workspace, equipment, protected time)

Predictor: A powerful mentor + strong institutional environment dramatically boosts success.

⭐ 5. Clear, Feasible, Milestone-Driven Research Plan

Winning AES grants consistently include:

Two or three sharply defined aims

Clear hypotheses

Timelines with realistic milestones

Defined paths to publication

Risk mitigation strategies

Predictor: Reviewers must see that your 1–2 year plans are achievable with the requested funds.

⭐ 6. Innovation That Is Truly New to the Epilepsy Field

AES places a high value on:

New models and technologies

AI/ML methods for seizure detection or prediction

Novel circuit or synaptic mechanisms

Platform technologies (e.g., optogenetics, viral vectors, neuromodulation)

Translational bridges (from animal → human → clinical feasibility)

Predictor: Innovation must be clearly articulated and tied to improving epilepsy outcomes.

⭐ 7. Career Trajectory & Long-Term Commitment to Epilepsy

AES places strong emphasis on cultivating future leaders.

Reviewers reward applicants who show:

A sustained interest in epilepsy

A publication record in epilepsy or seizure research

Clear plans to remain in the epilepsy research community

Participation in AES annual meetings and networks

Predictor: Demonstrating a long-term epilepsy research identity increases competitiveness.

⭐ 8. Strong Written Communication

High-scoring AES applications:

Are extremely clear and concise

Have a strong “Significance” section explaining how the project addresses an important unmet need

Use compelling, confident but scientifically accurate writing

Are visually clean with logical flow through sections

Predictor: Writing quality directly affects reviewer enthusiasm.

⭐ 9. Diversity, inclusion, and relevance to underserved epilepsy populations (emerging priority)

AES increasingly values proposals that:

Study underrepresented or rare epilepsy syndromes

Address health equity

Involve diverse communities in clinical studies

Increase diversity in the research workforce

Predictor: Explicitly addressing D&I strengthens many AES applications.

⭐ 10. AES Engagement and Community Presence

Not required—but historically correlated with success:

Presenting abstracts at AES

Participating in AES SIGs (Special Interest Groups)

Networking with AES investigators

Involvement in AES mentorship or trainee programs

Predictor: Active AES participation signals commitment and builds reviewer familiarity.

🏆 Summary Table

Success Predictor	Why It Matters
Epilepsy-focused research	AES mission alignment
Correct award match	Ensures expectations and project fit
Preliminary data	Proves feasibility
Strong mentorship	Critical for early-career applicants
Clear aims & milestones	Helps reviewers trust the plan
Innovation + impact	Core review criteria
Career commitment to epilepsy	AES invests in future leaders
Excellent writing	Increases reviewer enthusiasm
Equity and inclusion	Growing priority
AES community engagement	Signals seriousness & credibility

Specialties

Clinical Trials

Eligibility Requirements

Applicants must:

1. Hold an MD, DO, PhD, ScD, PharmD, RN, or equivalent degree.

2. Be either accepted into an epilepsy fellowship program or be enrolled in the first year of a 2-year fellowship program.

3. Be in a fellowship program at an appropriate institution before the start date. (Applicants with appointments at the level of Instructor, Adjunct Professor, Research Assistant, or Assistant or Associate Professor are not eligible, nor are graduate or medical students, medical residents, permanent government employees, or employees of private industry.).

4. Have a defined research plan that is relevant to antiepileptic drug therapy, with access to institutional resources to conduct the proposed project.

5. Have a qualified mentor(s) with expertise to supervise and provide guidance on epilepsy-related research.

6. Have not previously been awarded an AES Research and Training Fellowship for Clinicians award.

In addition:

7. Physician applicants whose research will involve patient care or direct involvement with patients must have completed all residency training and be licensed to practice medicine at their institution.

8. U.S. citizenship is not required. Preference will be given to applications for research to be conducted at U.S. institutions. Depending on available funds, applications may be considered for investigators outside the U.S. who otherwise meet the eligibility criteria.

9. Applicants from all backgrounds are encouraged to apply. Selections will be made without respect to race, gender, or any other protected characteristic or protected status.

Sponsor Details

Sponsor Institute/Organizations: American Epilepsy Society

Sponsor Type: Corporate/Non-Profit

Address: 141 W. Jackson Blvd. Suite 1065 Chicago, IL 60604 Phone: 312-883-3800 Fax: 312-896-5784

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity